Dermatologic drug formulary: An American Academy of Dermatology white paper

Journal of the American Academy of Dermatology

Volumn 34, Issue 1, 1996, Pages 99-109

  Steger, James W ^a   Wolverton, Steven E ^b   Greenberg, Robert D ^c   Ling, Mark R ^d   Resnick, Steven D ^e   James, William D ^f,g  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; DRUG VEHICLE; PRESERVATIVE; ANTI ACNE AGENT; ANTIPRURITIC AGENT; EMOLLIENT AGENT; GENERIC DRUG; HYDROQUINONE; KERATOLYTIC AGENT; LANOLIN ALCOHOL; MENTHOL; NON PRESCRIPTION DRUG; PETROLATUM; PHENOL; RETINOIC ACID; SALICYLIC ACID; STEROID; XIPAMIDE;

ARTICLE; DERMATOLOGY; MEDICAL SOCIETY; PHARMACY AND THERAPEUTICS COMMITTEE; PUBLICATION; UNITED STATES; VEHICLES; CHLOASMA; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG FORMULATION; DRUG INFORMATION; HOSPITAL PHARMACY; HUMAN; HYPERKERATOSIS; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

DERMATOLOGIC AGENTS; DERMATOLOGY; FORMULARIES; FORMULARIES, HOSPITAL; PHARMACY AND THERAPEUTICS COMMITTEE; PRESERVATIVES, PHARMACEUTICAL; SOCIETIES, MEDICAL; UNITED STATES; VEHICLES;

EID: 0029664356     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90841-5     Document Type: Article

References (22)

1. Francke DE, Latiolais CJ, Francke GN, et al. Mirror to hospital pharmacy. American Society of Hospital Pharmacists (1964:139-40). Excerpted in Am J Hosp Pharm 1986;43:2838-9.
2. Lipman AG. Drug use management. In: Brown TR, ed. Handbook of institutional pharmacy practice. 3rd ed. Bethesda, Md: American Society of Hospital Pharmacists, 1992:63-71.
3. 1994 Accreditation Manual for Hospitals: vol 1. Standards. Oakbrook Terrace, Ill: Joint Commission on Accreditation of Healthcare Organizations, 1993.
4. Field J. Practice formularies. Practitioner 1993;237:586-8.
5. Summers KH, Szeinbach SL. Formularies: the role of pharmacy-and-therapeutics (P&T) committees. Clin Ther 1993;15:433-41.
6. Kreling DH, Mucha RE. Drug product management in health maintenance organizations. Am J Hosp Pharm 1992; 49:374-81.
7. American Society of Hospital Pharmacists statement on the formulary system. Am J Hosp Pharm 1986;43:2839-41.
8. American Society of Hospital Pharmacists Statement on the pharmacy and therapeutics committee. Am J Hosp Pharm 1986;43:2841-2.
9. Hospital pharmacy management: forms, checklists, and guidelines: vol 1. Formulary management. Gaithersburg, Md: Aspen Publishers, 1994:1715.
10. Torres A. The use of PDA-approved medications for unlabeled (off-label) uses. Arch Dermatol 1994;130:32-6.
11. Ling MR. The message in the medium: how and why to choose a vehicle. Fitzpatrick's J Clin Dermatol 1995;3:13-9.
12. Stoughton RB. Are generic formulations equivalent to trade name topical glucocorticoids? Arch Dermatol 1987; 123:1312-4.
13. Jackson DB, Thompson C, McCormack JR, et al. Bioequivalence (bioavailability) of generic topical corticosteroids. J AM ACAD DERMATOL 1989;20:791-6.
14. Osterweil N. FDA evaluates the approval process for topical generics. Dermatology Times 1992;13:43.
15. Cornell RC, Stoughton RB. Correlation of vasoconstrictor assay and clinical activity in psoriasis. Arch Dermatol 1985;121:63-7.
16. Barry BW. Formulation of dermatologie vehicles. In: Dermatological formulations: percutaneous formulations. New York: Marcel Dekker, 1983:296-350.
17. Sabourin JR. Selecting a preservative for creams and lotions. Cosmet Toiletries 1986;101:93-8.
18. Rascati KL. Survey of formulary system policies and procedures. Am J Hosp Pharm 1992;49:100-3.
19. Ritchie DJ, Manchester RF, Rich MW, et al. Acceptance of a pharmacy-based, physician-edited hospital pharmacy and therapeutics committee newsletter. Ann Pharmacother 1992;26:886-9.
20. Abramowitz PW, Fletcher CV. Counterpoint: let's expand the formulary system and renew its vigor. Am J Hosp Pharm 1986;43:2834-8.
21. Szkutnik AJ. Extemporaneous formulations and quality assurance. In: Brown TR. ed. Handbook of institutional pharmacy practice. 3rd ed. Bethesda, Md: American Society of Hospital Pharmacists, 1992:237-44.
22. Black J, Griffin T, Beisel NW, et al. Implementation of an outpatient prescription drug formulary in a managed-care system. Am J Hosp Pharm 1988;45:561-5.